Document Detail


Hemangiopericytoma of the maxillary sinus and skull base.
MedLine Citation:
PMID:  2404907     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Since 1949, only 52 cases of hemangiopericytoma (HPC) of the nose and paranasal sinuses have been reported in the literature. Of the latter, only 2 originated from the maxillary sinus. This article reports 2 new cases. One arose in the maxillary sinus and involved the pterygopalatine fossa, skull base, and infratemporal fossa. The second tumor was located in the sphenoethmoidal recess. A new combination of techniques for resection of hemangiopericytoma of the skull base is described. Prognostic criteria for such tumors are reviewed, in conjunction with histological diagnosis.
Authors:
H M Abdel-Fattah; G L Adams; M R Wick
Related Documents :
23780547 - Reporting and methodological quality of systematic reviews in the orthopaedic literature.
8348727 - Waldenström's macroglobulinaemia presenting with cold urticaria and cold purpura.
Publication Detail:
Type:  Case Reports; Journal Article; Review    
Journal Detail:
Title:  Head & neck     Volume:  12     ISSN:  1043-3074     ISO Abbreviation:  Head Neck     Publication Date:    1990 Jan-Feb
Date Detail:
Created Date:  1990-03-06     Completed Date:  1990-03-06     Revised Date:  2006-10-05    
Medline Journal Info:
Nlm Unique ID:  8902541     Medline TA:  Head Neck     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  77-83     Citation Subset:  IM    
Affiliation:
Department of Otolaryngology, University of Minnesota, Minneapolis.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Hemangiopericytoma / diagnosis*,  surgery
Humans
Male
Maxillary Sinus Neoplasms / diagnosis*,  surgery
Paranasal Sinus Neoplasms / diagnosis*
Prognosis
Skull Neoplasms / diagnosis*,  surgery
Tomography, X-Ray Computed

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Serum tumor markers of head and neck cancer: current status.
Next Document:  A geochemical assessment of terrestrial gamma-ray absorbed dose rates.